Breaking News

Tweet TWEET

Geron Corporation Stockholders Encouraged to Contact Securities Law Firm about Investigation

Geron Corporation Stockholders Encouraged to Contact Securities Law Firm about
                                Investigation

PR Newswire

DALLAS, March 24, 2014

DALLAS, March 24, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons
announce an investigation of the board of Geron Corporation (NASDAQ: GERN).
Concerned GERN investors who purchased between June 16, 2013 and March 11,
2014 are encouraged to contact securities attorney Hamilton Lindley by
clicking here.

"After the March 12, 2014 announcement that the FDA put Geron's
Investigational New Drug application for imetelstat on full clinical hold,
stock plummeted more than 60%," said securities lawyer Hamilton Lindley. "Our
potential shareholder lawsuit will seek to ensure that all relevant
information is disclosed to Geron Corporation shareholders."

Deans & Lyons has significant experience representing shareholders in
securities lawsuits nationwide. GERN stockholders – or anyone with knowledge
about this situation – should contact lawyer Hamilton Lindley at
hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com

SOURCE Deans & Lyons LLP

Website: http://www.deanslyons.com
 
Press spacebar to pause and continue. Press esc to stop.